Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
Feldmann
M
M
The Mathilda & Terrence Kennedy Institute of Rheumatology, Hammersmith, London, UK.
Brennan
F
F
Paleolog
E
E
Taylor
P
P
Maini
R N
RN
D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000276:immunology* / Q000628:therapy*; D016207:Cytokines / Q000097:blood; D003602:Cytotoxicity, Immunologic; D015536:Down-Regulation; D006801:Humans; D007167:Immunotherapy; D066298:In Vitro Techniques; D018836:Inflammation Mediators / Q000097:blood; D009389:Neovascularization, Pathologic; D009500:Neutralization Tests; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D016207:Cytokines; D018836:Inflammation Mediators; D014409:Tumor Necrosis Factor-alpha